Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.
2.

Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.

Migliacci R, Falcinelli F, Imperiali P, Floridi A, Nenci GG, Gresele P.

Ital Heart J. 2004 May;5(5):371-7.

PMID:
15185901
3.

Dermatan sulphate as an antithrombotic drug.

Nenci GG.

Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):303-7. Review.

4.

Low molecular weight heparins: are they interchangeable? No.

Nenci GG.

J Thromb Haemost. 2003 Jan;1(1):12-3. Review. No abstract available.

5.

Inhibition of fluid phase and clot-bound thrombin by the thrombin exosite I ligand LU 58463: comparison with heparin and hirudin.

Filippucci E, Agnelli G, Leone M, Nenci GG.

Haematologica. 2002 Oct;87(10):1116-7. No abstract available.

6.

[Low-molecular weight heparin: questions asked to the physician].

Nenci GG, Prisco D.

Recenti Prog Med. 2001 Nov;92(11 Suppl):63A-66A. Italian. No abstract available.

PMID:
11822108
7.

Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.

Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F; Mesoglycan Intermittent Claudication Group.

Thromb Haemost. 2001 Nov;86(5):1181-7.

PMID:
11816704
9.

Low molecular weight heparins for arterial thrombosis.

Nenci GG, Minciotti A.

Vasc Med. 2000;5(4):251-8. Review.

PMID:
11213238
10.

Antithrombotic drugs for the secondary prevention of ischemic stroke.

Nenci GG, Goracci S.

Ann Ital Med Int. 2000 Oct-Dec;15(4):282-90. Review.

PMID:
11202630
13.

[Diabetes, coagulation and vascular events].

Nenci GG, Paliani U.

Recenti Prog Med. 2000 Feb;91(2):86-90. Review. Italian.

PMID:
10748654
14.

Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats.

Costantini V, Deveglia R, Stabile A, Nenci GG.

Blood Coagul Fibrinolysis. 2000 Jan;11(1):7-13.

PMID:
10691095
15.

[Gene therapy of critical ischemia of the legs. Improvement of genetic transfection efficiency of endothelial cells in vitro, using cationic liposomes and protamine sulfate].

Costantini V, Allegrucci M, Paolucci MC, Ricci M, Stabile AM, Presilla MC, Nenci GG.

Minerva Cardioangiol. 1999 Dec;47(12):662-3. Italian. No abstract available.

PMID:
10670251
16.

[Alprostadil combined with antithrombotic drugs. Effects on hemorrhage time].

Minciotti A, Goracci S, Nenci GG.

Minerva Cardioangiol. 1999 Dec;47(12):651. Italian. No abstract available.

PMID:
10670245
17.

Platelets release their lysosomal content in vivo in humans upon activation.

Ciferri S, Emiliani C, Guglielmini G, Orlacchio A, Nenci GG, Gresele P.

Thromb Haemost. 2000 Jan;83(1):157-64.

PMID:
10669170
18.

[Arteriothrombosis as a polyvascular disease. Common therapeutic aspects of different localizations].

Nenci GG.

Minerva Cardioangiol. 1999 Nov;47(11):371. Italian. No abstract available.

PMID:
10641399
19.

Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate.

Nucciarelli F, Gresele P, Nardicchi V, Porcellati S, Macchioni L, Nenci GG, Goracci G.

FEBS Lett. 1999 Apr 30;450(1-2):39-43.

21.

Dermatan sulphate in patients with heparin-induced thrombocytopenia.

Taliani MR, Agnelli G, Nenci GG, Gianese F.

Br J Haematol. 1999 Jan;104(1):87-9.

PMID:
10027716
23.

Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests.

Gresele P, Catalano M, Giammarresi C, Volpato R, Termini R, Ciabattoni G, Nenci GG, Davì G.

Thromb Haemost. 1997 Dec;78(6):1434-7.

PMID:
9423790
24.

Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.

Davì G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci GG, Ciabattoni G, Patrono C.

Circulation. 1997 Jul 1;96(1):69-75.

PMID:
9236419
25.

Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents.

Iorio A, Nucciarelli F, Renga C, Nenci GG, Gianese F, Agnelli G.

Haemostasis. 1997 Mar-Apr;27(2):85-90.

PMID:
9212356
26.

Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography--an overview analysis.

Ricotta S, Iorio A, Parise P, Nenci GG, Agnelli G.

Thromb Haemost. 1996 Dec;76(6):887-92. Review.

PMID:
8972006
27.

Post-discharge deep-vein thrombosis after orthopaedic surgery.

Agnelli G, Iorio A, Ricotta S, Parise P, Nenci GG.

Lancet. 1996 Oct 26;348(9035):1180. No abstract available.

PMID:
8888208
28.

Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.

Ribaldi E, Mezzasoma AM, Francescangeli E, Prosdocimi M, Nenci GG, Goracci G, Gresele P.

Br J Pharmacol. 1996 Jul;118(6):1351-8.

29.
30.

Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets.

Iorio P, Gresele P, Stasi M, Nucciarelli F, Vezza R, Nenci GG, Goracci G.

FEBS Lett. 1996 Mar 4;381(3):244-8.

31.
32.

Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein thrombosis after hip surgery.

Ascani A, Radicchia S, Parise P, Nenci GG, Agnelli G.

Thromb Haemost. 1996 Feb;75(2):239-41.

PMID:
8815567
34.

Prolonged antithrombin activity of low-molecular-weight heparins. Clinical implications for the treatment of thromboembolic diseases.

Agnelli G, Iorio A, Renga C, Boschetti E, Nenci GG, Ofosu FA, Hirsh J.

Circulation. 1995 Nov 15;92(10):2819-24.

PMID:
7586247
35.

Clinical outcome of orthopaedic patients with negative lower limb venography at discharge.

Agnelli G, Ranucci V, Veschi F, Rinonapoli E, Lupattelli L, Nenci GG.

Thromb Haemost. 1995 Oct;74(4):1042-4.

PMID:
8560410
36.

Effects of desmopressin on hemostasis in patients with liver cirrhosis.

Agnelli G, Parise P, Levi M, Cosmi B, Nenci GG.

Haemostasis. 1995 Sep-Oct;25(5):241-7.

PMID:
7489963
37.

A simple chromogenic substrate assay of tissue factor pathway inhibitor activity in plasma and serum.

Berrettini M, Malaspina M, Parise P, Lucarelli G, Kisiel W, Nenci GG.

Am J Clin Pathol. 1995 Apr;103(4):391-5.

PMID:
7726132
38.

Platelet glycohydrolase activities: characterization and release.

Emiliani C, Martino S, Orlacchio A, Vezza R, Nenci GG, Gresele P.

Cell Biochem Funct. 1995 Mar;13(1):31-9.

PMID:
7720188
39.

Original Article: Albumin Prevents TxB, Formation from Thrombin-stimulated Human Platelets by Sequestering the Liberated Arachidonic Acid in the Extracellular Space.

Porcellati S, Gresele P, Stasi M, Buratta S, Horrocks LA, De Franceschi S, Nenci GG, Goracci G.

Platelets. 1995;6(6):381-7. doi: 10.3109/09537109509078476.

PMID:
21043769
40.

Diagnosis of deep vein thrombosis in asymptomatic high-risk patients.

Agnelli G, Radicchia S, Nenci GG.

Haemostasis. 1995 Jan-Apr;25(1-2):40-8. Review.

PMID:
7896221
41.

Dermatan sulphate in heparin-induced thrombocytopenia.

Agnelli G, Iorio A, de Angelis V, Nenci GG.

Lancet. 1994 Nov 5;344(8932):1295-6. No abstract available.

PMID:
7968002
42.

Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial.

Marroni M, Gresele P, Landonio G, Lazzarin A, Coen M, Vezza R, Sinnone MS, Boschetti E, Nosari AM, Stagni G, Nenci GG, Pauluzzi S.

Ann Intern Med. 1994 Sep 15;121(6):423-9.

PMID:
8053616
43.

Subcutaneous factor IX administration to patients with hemophilia B.

Berrettini M, Iorio P, Nenci GG, Arcieri P, Mariani G.

Am J Hematol. 1994 Sep;47(1):61-2. No abstract available.

PMID:
8042620
44.

Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C.

Vezza R, Roberti R, Nenci GG, Gresele P.

Blood. 1993 Nov 1;82(9):2704-13.

45.

Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.

Parise P, Morini M, Agnelli G, Ascani A, Nenci GG.

Blood Coagul Fibrinolysis. 1993 Oct;4(5):721-7.

PMID:
8292721
46.

Platelet thromboxane A2 receptor number and function in normal and hypertensive pregnancy.

Di Renzo GC, Coata G, De Franceschi S, Chiaradia E, Kett A, Vezza R, Nenci GG, Cosmi EV, Gresele P.

Am J Reprod Immunol. 1993 Sep-Oct;30(2-3):160-6.

PMID:
8311925
47.
48.

Features of thrombi and diagnostic accuracy of impedance plethysmography in symptomatic and asymptomatic deep vein thrombosis.

Agnelli G, Cosmi B, Radicchia S, Veschi F, Boschetti E, Lupattelli L, Rinonapoli E, Nenci GG.

Thromb Haemost. 1993 Aug 2;70(2):266-9.

PMID:
8236133
49.

Cloricromene inhibits G-protein-mediated activation of phospholipase A2 in human platelets.

Stasi M, Gresele P, Prosdocimi M, Porcellati S, Quero E, Pieretti G, Nenci GG, Goracci G.

J Lipid Mediat. 1993 Jul;7(3):253-67.

PMID:
8219005
50.

Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma.

Gresele P, Dottorini M, Selli ML, Iannacci L, Canino S, Todisco T, Romano S, Crook P, Page CP, Nenci GG.

J Allergy Clin Immunol. 1993 Apr;91(4):894-902.

PMID:
8473678

Supplemental Content

Loading ...
Support Center